Skip to content

Opening book details…

About this Medicine article

A multicentre phase II study of the efficacy and safety of docetaxel as first-line treatment of advanced breast cancer: Report of the Clinical Screening Group of the EORTC by Fumoleau, P.; Chevallier, B.; Kerbrat, P.; Krakowski, Y.; Misset, J.-L.; Maugard-Louboutin, C.; Dieras, V.; Azli, N.; Bougon, N.; Riva, A.; Roche, H. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Fumoleau, P.; Chevallier, B.; Kerbrat, P.; Krakowski, Y.; Misset, J.-L.; Maugard-Louboutin, C.; Dieras, V.; Azli, N.; Bougon, N.; Riva, A.; Roche, H.
Publisher
Oxford University Press; Elsevier BV (ISSN 0923-7534)
Published
1996
Language
EN
Field
Medicine (Health Sciences)

More by Fumoleau, P.; Chevallier, B.; Kerbrat, P.; Krakowski, Y.; Misset, J.-L.; Maugard-Louboutin, C.; Dieras, V.; Azli, N.; Bougon, N.; Riva, A.; Roche, H.

Browse all works by Fumoleau, P.; Chevallier, B.; Kerbrat, P.; Krakowski, Y.; Misset, J.-L.; Maugard-Louboutin, C.; Dieras, V.; Azli, N.; Bougon, N.; Riva, A.; Roche, H.